Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Epidemiology of Skin Cancer and Its Trend in Iran Publisher



Razi S1 ; Enayatrad M2 ; Mohammadianhafshejani A3 ; Salehiniya H4, 5 ; Fathaliloydizaji M6 ; Soltani S7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Fayyaz Bakhsh Hospital, Social Security Organization, Tehran, Iran
  7. 7. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Preventive Medicine Published:2015


Abstract

Background: One of the most common cancers is skin cancer worldwide. Since incidence and cost of treatment of the cancer are increasing, it is necessary to further investigate to prevent and control this disease. This study aimed to determine skin cancer trend and epidemiology in Iran. Methods: This study was done based on existing data. Data used in this study were obtained from a national registry of cancer cases and the Disease Management Center of Ministry of Health in Iran. All cases registered in the country were included during 2004–2008. Incidence rates were reported based on the direct method and standard population of World Health Organization. Results: Based on the results of this study, the incidence of skin cancer is rising in Iran and the sex ratio was more in men than women in all provinces. The age-standardized incidence rate (ASR) of skin cancer was highest in males in Semnan, Isfahan, and Hamedan provinces (34.9, 30.80, and 28.84, respectively). The highest ASRs were seen in females in Semnan, Yazd, and Isfahan provinces (26.7, 24.14, and 18.97, respectively). The lowest ASR in male was observed in Sistan and Baluchestan, and in female in Hormozgan provinces. Conclusions: The incidence of skin cancer is increasing in the country. Therefore, the plan for the control and prevention of this cancer must be a high priority for health policy makers. © 2015 Razi S.
Other Related Docs
9. Cancers of Urinary System; Prevalence, Demographic, Jundishapur Journal of Chronic Disease Care (2019)
12. Frequency of Cancer Associated With Children and Adolescents, New Emirates Medical Journal (2024)
14. Iranian Women Diagnosed With Breast Cancer a Decade Earlier Than British Women?, Journal of Kerman University of Medical Sciences (2022)
16. Thyroid Cancer in Isfahan Province, Iran; Prevalence and Demographic Characteristics, Jundishapur Journal of Chronic Disease Care (2019)
20. Trends in Colorectal Cancer Incidence in Iran, Journal of Mazandaran University of Medical Sciences (2015)
22. Prevalence of Lung Cancer in Isfahan Province, Iran, Journal of the Egyptian National Cancer Institute (2018)
27. The Economic Cost of Cancer Treatment in Iran, Journal of Education and Health Promotion (2023)
28. Death Portrait of Isfahan Province in Years 2007-2011, International Journal of Preventive Medicine (2016)
31. Prevalence of Stomach Cancer in Isfahan Province, Iran, The Gulf journal of oncology (2018)
32. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
34. The Risk Factors of Prostate Cancer: A Multicentric Case-Control Study in Iran, Asian Pacific Journal of Cancer Prevention (2007)
39. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
43. Incidence of Breast and Cervical Intraepithelial Lesions: Results of a Screening Program for Women, Journal of Obstetrics, Gynecology and Cancer Research (2022)